The trajectory of the erectile dysfunction drug presents a complex picture for shareholders. While the initial launch generated substantial profits, the end of its intellectual property protection opened the avenue to https://socialmediaentry.com/story7145739/viagra-and-the-pharmaceutical-industry-a-precarious-investment